Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthopediatrics (KIDS) Common Equity (2016 - 2025)

Orthopediatrics has reported Common Equity over the past 11 years, most recently at $346.6 million for Q4 2025.

  • Quarterly results put Common Equity at $346.6 million for Q4 2025, down 2.25% from a year ago — trailing twelve months through Dec 2025 was $346.6 million (down 2.25% YoY), and the annual figure for FY2025 was $346.6 million, down 2.25%.
  • Common Equity for Q4 2025 was $346.6 million at Orthopediatrics, down from $349.3 million in the prior quarter.
  • Over the last five years, Common Equity for KIDS hit a ceiling of $383.3 million in Q3 2022 and a floor of $215.0 million in Q1 2022.
  • Median Common Equity over the past 5 years was $355.0 million (2024), compared with a mean of $323.3 million.
  • Biggest five-year swings in Common Equity: decreased 8.6% in 2021 and later soared 73.52% in 2023.
  • Orthopediatrics' Common Equity stood at $225.4 million in 2021, then surged by 68.01% to $378.6 million in 2022, then decreased by 0.43% to $377.0 million in 2023, then decreased by 5.96% to $354.6 million in 2024, then fell by 2.25% to $346.6 million in 2025.
  • The last three reported values for Common Equity were $346.6 million (Q4 2025), $349.3 million (Q3 2025), and $355.5 million (Q2 2025) per Business Quant data.